Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

B2B sales

- PMLiVE

AstraZeneca’s Nexium claims top slot among leading US drugs

Displaces Sanofi's Plavix according to new IMS Health figures from Drugs.com

- PMLiVE

Novartis challenge to India patent law postponed

And Bayer's Nexavar case also delayed

- PMLiVE

Lundbeck promotes Andreas Eggert and Klaus Abel to senior commercial roles

Will oversee launch of new medicines and Otsuka partnership respectively

- PMLiVE

COPD-asthma market to reach $47bn in 2017

Aging population, increased pollution and new drugs will lead to growth, says report

- PMLiVE

Driving early clinical and commercial alignment

Real-world studies can provide evidence to ensure that your brand resonates with your customers

Health economics teams are making significant use of patient reported outcomes

The measures impact reimbursement and also aid payer communication

Pfizer launches Latin American vaccine education campaign

Public-facing pneumococcal disease campaign will cover 14 countries in the region

Allergan signs $1.4bn eye drug deal with Molecular Partners

Will develop DARPin proteins to target AMD and other eye conditions

- PMLiVE

US mobile health app prescribing pilot begins

Will focus on six areas, including cardiology, rheumatology and endocrinology health apps

- PMLiVE

FDA delays review deadline for Pfizer arthritis drug

Follows addition of new submission data for tofacitinib

Sanofi pulls Campath in EU and US

Withdraws cancer drug to avoid its off-label use in MS

- PMLiVE

Manish Singh resigns as CEO of ImmunoCellular Therapeutics

Replaced on interim basis by company chair and chief scientific officer Dr John Yu

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links